We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go: Extended investment: Withheld
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go: Extended investment: £295,000
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go: TBC investment: £127,001
GP Nutrition is a nutrition company that creates products meant to deliver sustainable weight loss. This award-winning company was created by Gabriela Peacock, a celebrity nutritionist. It has 13,000 global customers who have bought more than 30,000 packs. In June'19, the company reached trading of £50k per month. It has produced 22 products that are now sold in 30 countries. GP Nutrition has delivered revenue of £377k and an EBITDA of £813,389. Nutrition's vision is to solve the 95% failure rate of diets in the USA and the UK.
days to go: Expired investment: £309,890
Clinical Net is a health-tech firm focused on revolutionizing access to innovative clinical trials. Their AI platform swiftly connects patients with suitable trials, addressing the challenge of low participation rates and delays that hinder pharmaceutical research. With over 69,000 trials globally, their solution aims to streamline the cumbersome and time-consuming process of trial matching, making it more efficient and accessible within 5 minutes. This innovative approach targets the $3.73 billion patient recruitment market while ensuring individuals have easier access to groundbreaking treatments.
days to go: Expired investment: £136,827
Bright Salon is a smartphone app that is designed to allow hair and beauty salons grow their business. The app can be used to fill in the gaps from last minute cancellations. The app can also be used as an alternative to paper-based loyalty schemes. Using the app for a loyalty scheme allows customers to see exactly how many points they have and the milestones they have to reach to acheive certain rewards.
days to go: Expired investment: £28,640
BMM Networks is a company specialising in providing electric vehicle charging solutions throughout the UK. Currently, there are about 250,000 electric vehicles (EV) in the UK, with the hope that it will increase to 1 million by 2022. But this transition requires dependable and safe On-Street and Workplace charging stations. The UK Government, through the Office for Low Emission Vehicles (OLEV), has dedicated over £900 million of funding to expanding EV usage, of which £500 million is in scope for the BMM charging point business model. With the help of its delivery partner, BMM Energy Solutions Limited, BMM Networks has engaged with several local authorities to develop charging solutions. The company is one of the 10 approved framework providers for OLEV funded projects. Within this setup, OLEV will fund 75% of the installation cost or £5,000 for each charging point, leaving BMM to fund the balance of £1,250 per charger. This will enhance the coverage of charging points thereby boosting EV sales. The company is seeking £1.375 million of equity funding to boost its brand identity and business opportunities.

Pitch Rated

72%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: Withheld
WeVee is a platform that brings Electric Vehicles (EVs) into one place so that potential customers can browse across different models and makes, compare them, get relevant pricing, and configure a leasing plan, with the help of reliable EV experts. The company asserts that its pricing configurator pulls from some of the UK's top lenders such as Lex Autolease, LeasePlan, Arval UK, and ALD Automotive, using Application Programming Interface (API's) to show the best price for each lease configuration. WeVee argues that over 800 vehicles have been ordered on its portal to date. It has also earned £830,000 worth of revenue since launch and garnered 350+ 5-star Trustpilot reviews. WeVee will use the investment for technology development, marketing, contingency purposes, towards paying its tech, leadership, marketing, and operations teams, and upgrades to its IT hardware.

Pitch Rated

83%

Gold

rating powered by

CROWD RATING™

days to go: Expired investment: £1,602,196
Urban is a wellness app that allows customers to book massages, beauty treatments, personal training and more at the customer's doorstep in 60 minutes. The company's practitioners are already operating in London, Paris, Manchester and Birmingham covering all aspects of wellness, from massage to mindfulness and beyond. Urban has delivered over 650,000 appointments till date, witnessed £43 million in cumulative sales value since August 2018, onboarded 3,800 partner practitioners, and saw 7,300+ reviews on Apple app store with an average rating of 4.8/5 stars. It will use the investment to drive towards Operating Expense (OpEx) profitability by the end of Q1 2021, reach EBITDA positive by the end of 2021, and scale into new markets through remote expansion.
days to go: Expired investment: £5,877,517
Swing has pioneered an IoT-connected micro-gym, the Swing Box, equipped with integrated free weights suitable for outdoor use. This innovative gym solution includes adjustable backrests and various dumbbells and kettlebells, catering to users of all fitness levels. Users can conveniently locate, reserve, and unlock the Swing Box using any smartphone, aiming to combat physical inactivity, which contributes to a significant number of deaths and costs the UK £7.4 billion annually. Swing's solution addresses the barriers of affordability, accessibility, and time in exercise by providing on-demand, free-access outdoor micro-gyms in communal parks and green spaces. With over 90% of UK residents within a 10-minute walk of public parks and only 32% meeting NHS guidelines for muscle-strength activity, Swing aims to lease these boxes to grant public access with leaseholders paying an annual fee of £2500 per box, covering maintenance and operations.
days to go: Expired investment: £287,590
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph